A new narrative review discussing regenerative peptides, including BPC-157, for inferior alveolar nerve injury was published on October 27, 2026. The publication appeared in Frontiers in Dental Medicine under the title "Regenerative peptides for inferior alveolar nerve injury: a narrative review." BPC-157 remains classified as an unapproved compound used only in research settings. This entry reflects the publication of the review itself and does not describe specific findings, conclusions, or outcomes from the paper. No efficacy or safety data from the review are being reported here. Readers interested in the full scope of the discussion, including any methodology or conclusions presented by the authors, should consult the original source directly. As with all narrative reviews, the content synthesizes existing literature rather than presenting new experimental results. The listing here is intended only to note that this publication now exists in the literature and includes BPC-157 as a topic of discussion. No regulatory status changes have been reported in connection with this publication. For additional background on BPC-157, including its current research classification and general context, readers can consult the compound overview.
BPC-157 Reviewed in New Narrative Publication on Nerve Injury
Source: https://pubmed.ncbi.nlm.nih.gov/43011877/